DK2379580T3 - Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner - Google Patents

Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Info

Publication number
DK2379580T3
DK2379580T3 DK09795876.3T DK09795876T DK2379580T3 DK 2379580 T3 DK2379580 T3 DK 2379580T3 DK 09795876 T DK09795876 T DK 09795876T DK 2379580 T3 DK2379580 T3 DK 2379580T3
Authority
DK
Denmark
Prior art keywords
antibacterial agents
treating gram
positive infections
unknown
unknown antibacterial
Prior art date
Application number
DK09795876.3T
Other languages
Danish (da)
English (en)
Inventor
Andre Lee Pearson
Chester A Metcalf Iii
Jing Li
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Application granted granted Critical
Publication of DK2379580T3 publication Critical patent/DK2379580T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09795876.3T 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner DK2379580T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13987508P 2008-12-22 2008-12-22
PCT/US2009/068747 WO2010075215A1 (en) 2008-12-22 2009-12-18 Novel antibacterial agents for the treatment of gram positive infections

Publications (1)

Publication Number Publication Date
DK2379580T3 true DK2379580T3 (da) 2014-01-20

Family

ID=41718893

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09795876.3T DK2379580T3 (da) 2008-12-22 2009-12-18 Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner

Country Status (26)

Country Link
US (3) US8507647B2 (enExample)
EP (2) EP2379580B1 (enExample)
JP (1) JP5670914B2 (enExample)
KR (1) KR101717795B1 (enExample)
CN (1) CN102325787B (enExample)
AR (1) AR074833A1 (enExample)
AU (1) AU2009330245C1 (enExample)
BR (1) BRPI0923567A2 (enExample)
CA (1) CA2747965C (enExample)
CY (1) CY1114883T1 (enExample)
DK (1) DK2379580T3 (enExample)
ES (1) ES2442167T3 (enExample)
HR (1) HRP20131170T1 (enExample)
IL (1) IL213638A0 (enExample)
MX (1) MX2011006803A (enExample)
NZ (1) NZ594019A (enExample)
PL (1) PL2379580T3 (enExample)
PT (1) PT2379580E (enExample)
RS (1) RS53152B (enExample)
RU (1) RU2512396C2 (enExample)
SG (1) SG172299A1 (enExample)
SI (1) SI2379580T1 (enExample)
SM (1) SMT201400037B (enExample)
TW (1) TWI444198B (enExample)
WO (1) WO2010075215A1 (enExample)
ZA (1) ZA201104693B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013013760A (es) * 2011-05-26 2014-01-08 Cubist Pharm Inc Composiciones de cb-183, 315 y metodos relacionados.
US10377699B2 (en) * 2013-11-06 2019-08-13 The University Of Hong Kong Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
WO2015172047A1 (en) * 2014-05-08 2015-11-12 Merck Sharp & Dohme Corp. Cyclic peptide compounds and related methods, salts and compositions
US11667674B2 (en) * 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
CR20180499A (es) * 2016-04-22 2019-01-25 Astrazeneca Ab Inhibidores de mcl1 macrocicliclos para tratar el cancer
US10098890B2 (en) 2016-10-29 2018-10-16 Cipla Limited Stable carfilzomib formulations
IT201600127655A1 (it) * 2016-12-16 2018-06-16 Gnosis Spa Processo per la purificazione di antibiotici lipopolipeptidici
US10072045B1 (en) 2017-06-26 2018-09-11 Ramapo Pharmaceuticals, Inc. Antibacterial lipopeptides and methods for their preparation and use
US10526343B2 (en) 2018-03-26 2020-01-07 University Of Sharjah Heterocyclic systems and pharmaceutical applications thereof
RU2762182C1 (ru) * 2020-12-08 2021-12-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Гауземицины А и В - гликолипопептидные антибактериальные антибиотики и способ их получения

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
USRE32333E (en) 1978-10-16 1987-01-20 Eli Lilly And Company A-21978 Antibiotics and process for their production
USRE32455E (en) 1978-10-16 1987-07-07 Eli Lilly And Company A-21978 antibiotics and process for their production
IE55221B1 (en) 1982-02-27 1990-07-04 Beecham Group Plc Antibacterial 1-normon-2-yl-heterocyclic compounds
USRE32310E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32311E (en) * 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4537717A (en) 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CN1051200A (zh) 1984-10-09 1991-05-08 伊莱利利公司 制备抗菌素a-21978c复合物或因子的方法
ZA883887B (en) 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US5039660A (en) * 1988-03-02 1991-08-13 Endocon, Inc. Partially fused peptide pellet
IL98349A (en) * 1990-06-07 1995-05-26 Lilly Co Eli Diphylase lipopeptide
WO1995005384A1 (en) 1993-08-13 1995-02-23 Smithkline Beecham Plc Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE544851T1 (de) 1996-03-08 2012-02-15 Astellas Pharma Inc Verfahren zur deacylierung von zyklischen lipopeptiden
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
HU230656B1 (hu) 1998-09-25 2017-06-28 Cubist Pharmaceuticals Llc Daptomicin alkalmazása
AU3434501A (en) 1999-11-03 2001-05-14 Whitaker Corporation, The Optoelectric module for multi-fiber arrays
CN1423656A (zh) * 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
BR0017026A (pt) * 1999-12-15 2003-01-07 Cubist Pharm Inc Lipeptìdeos como agentes antibacterianos
IL150224A0 (en) 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
US20060014674A1 (en) * 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
WO2003017924A2 (en) 2001-08-06 2003-03-06 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
RU2007121705A (ru) * 2004-11-12 2008-12-20 Кьюбист Фармасьютикалз Антиинфекционные липопептиды

Also Published As

Publication number Publication date
AU2009330245C1 (en) 2013-09-26
EP2379580B1 (en) 2013-10-23
RU2011130278A (ru) 2013-01-27
RU2512396C2 (ru) 2014-04-10
WO2010075215A1 (en) 2010-07-01
TW201028161A (en) 2010-08-01
SI2379580T1 (sl) 2014-02-28
CN102325787A (zh) 2012-01-18
AU2009330245B2 (en) 2013-05-02
EP2379580A1 (en) 2011-10-26
HRP20131170T1 (hr) 2014-01-03
AU2009330245A1 (en) 2011-08-04
US20100184649A1 (en) 2010-07-22
ES2442167T3 (es) 2014-02-10
JP2012513467A (ja) 2012-06-14
US8507647B2 (en) 2013-08-13
PL2379580T3 (pl) 2014-05-30
SMT201400037B (it) 2014-05-07
EP2674437A1 (en) 2013-12-18
TWI444198B (zh) 2014-07-11
JP5670914B2 (ja) 2015-02-18
NZ594019A (en) 2013-08-30
SG172299A1 (en) 2011-07-28
MX2011006803A (es) 2011-09-06
BRPI0923567A2 (pt) 2016-09-27
RS53152B (sr) 2014-06-30
ZA201104693B (en) 2013-01-30
US20150337013A1 (en) 2015-11-26
KR20110114592A (ko) 2011-10-19
CN102325787B (zh) 2014-05-28
AR074833A1 (es) 2011-02-16
CY1114883T1 (el) 2016-12-14
CA2747965A1 (en) 2010-07-01
CA2747965C (en) 2017-06-27
PT2379580E (pt) 2014-01-20
IL213638A0 (en) 2011-07-31
US20140073558A1 (en) 2014-03-13
KR101717795B1 (ko) 2017-03-17
HK1161886A1 (en) 2012-08-10

Similar Documents

Publication Publication Date Title
SMT201500117B (it) Composti antibatterici
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
BRPI0820656A2 (pt) Tiazóis condensados antibacterianos
EP2223788A4 (en) CUT PROCESSING MECHANISM
ATE507225T1 (de) Antibakterielle polycyclische harnstoffverbindungen
DE602008003471D1 (de) Schlüsselloses Zugangssystem
DK2331687T3 (da) Antimikrobielle midler
DK2034997T3 (da) Antibakterielle sammensætninger
BRPI0915059A2 (pt) conjunto de cateter de lavagem broncoalveolar
PL2464645T3 (pl) Skondensowane heterocykliczne związki jako modulatory kanałów jonowych
BRPI0919695A2 (pt) proporcionando resultados de pesquisa
DK2350116T3 (da) Behandling af biofilm
EP2173170A4 (en) ANNEXED HETEROCYCLES
SMT201400037B (it) Nuovi agenti antibatterici per il trattamento di infezioni grampositive
BRPI0720220A2 (pt) Derivados de quinolinas antibacterianos
DK2330887T3 (da) Behandlingsindretning
DK2353259T3 (da) Meddelelsesforarbejdning
GB0816679D0 (en) Compounds for treating viral infections
BRPI0920895A2 (pt) compostos antibióticos de oxazolidinona tricíclica
EP2460405A4 (en) ANTIBACTERIAL ACTIVE SUBSTANCE
DK2235041T3 (da) Antimikrobielle forbindelser
EP2358768A4 (en) Crosslinked polyvinylpyrrolidone compositions
HRP20150195T1 (xx) Antibakterijski peptidi
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas